Skip to main content
Skip to content
Case File
efta-efta01518898DOJ Data Set 10Correspondence

EFTA Document EFTA01518898

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01518898
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
CHISLAINE MAXWELL ACCT. For the Period 9/1/I3 to 9/30/13 Equity Summary Asset Categories Beginning Market Value Ending Market Value Change In Value Current Allocation US Large Cap Equity 292.573.99 299.641.71 7.067,72 6% US Small/Mid Cap Equity 4.290.00 10.050.00 5.760.00 1% Non•US Equity 135.18 146.86 11.68 1% Preferred Stocks 445.152 00 444.174 00 (978.00) 9% Concentrated 8 Other Equity 213.721 50 215.609 00 1.887.50 4% Total Value $955,872.67 $969,621.57 513,748.90 21% \la rket Value/Cost Current Period Value Market Value 969,621 57 Tar. Cost 944,362 24 Unrealized Gall Loss 25,259 33 Estimated Annual Income 50.794 36 Accrued DI. deeds 7 305 33 Yield 5.22% J.P.Morgan Asset Categories Unlined Stocks Non-VS Equity US Sintitilisel Cap Equity Concentrated & Other EquilY US Largo Cap Equity Equity as a percentage of your portfolio 21 (s Account Page 5 n' 34 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00046156 SDNY_GM_003 15354 EFTA01518898

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.